top of page

Buswell Biomedical Newsletter



Greetings,

As we navigate the hustle and bustle of life, we find ourselves compelled to share some exciting updates with you in this unscheduled edition of our newsletter.



Recently, I had the pleasure of participating in the "Think Big with Dan and Qasim" podcast, where we delved into the realm of biomedical breakthroughs. Titled "Revolutionizing Health: Sheila Buswell's Biomedical Breakthroughs | CEO & Co-founder Insights," this episode, though shorter than their usual podcasts, underwent some edits that may have affected its accuracy. I invite you to engage in a little detective work as you listen or watch the podcast (I prefer  an audio-only format). Feel free to spot the edits and inaccuracies—it's a fun game! You can find the link in this email or on our website under the "Podcast Appearances" section.



On another note, I recently underwent a unique interview experience with Gener8tor, an exclusive accelerator based in Nebraska. The process was both challenging and stressful, as I faced rapid-fire questions displayed on my screen, leaving me only a minute to formulate and record my responses. This invitation-only accelerator presents a significant opportunity, offering a $100,000 investment in exchange for a 7.5% ownership stake in our company. While this could theoretically lower our company's value, the potential benefits, including a strengthened network and our first investor, are substantial. I've chosen a hybrid model, committing to nine trips to either Omaha or Lincoln over 12 weeks if we secure a spot. After the intense interview, I can't predict the outcome, but I can say that by question 8 out of 14, my focus shifted from the result to the experience itself.



Looking back at 2023, Buswell Biomedical proudly secured a patent for our entire device, marking a significant milestone in our journey. While a full-sized prototype is still in progress, we're inching closer to completion. The year 2023 has presented us with numerous accomplishments and challenges, but we approach 2024 with optimism and hope for the continued growth and success of Buswell Biomedical.

Thank you for your ongoing support!

Best regards,

Sheila Buswell







8 views0 comments

Comments


bottom of page